Disposable Biopsy Needle Market: Global Industry Growth, Trends, and Forecast

The Disposable Biopsy Needle Market is witnessing steady growth as healthcare providers increasingly adopt minimally invasive diagnostic procedures and single-use medical devices. Disposable biopsy needles are widely used to collect tissue samples for diagnostic evaluation, particularly in oncology, gastroenterology, cardiology, and pulmonology. According to Wise Guy Reports, the market was valued at USD 2.0 billion in 2024 and is expected to reach USD 3.5 billion by 2035, expanding at a CAGR of approximately 5.4% from 2025 to 2035.

The increasing prevalence of cancer and other chronic diseases is a major factor supporting market demand. Growing awareness of early diagnosis and screening programs is also encouraging healthcare facilities to perform more biopsy procedures. At the same time, the shift toward single-use instruments is helping reduce infection and cross-contamination risks.

Technological advancements are further improving biopsy accuracy and safety. Enhanced needle designs, automated biopsy systems, and ultrasound-guided procedures are creating opportunities for manufacturers. Core biopsy needles, fine-needle aspiration needles, and vacuum-assisted biopsy needles serve different clinical requirements.

North America currently represents the largest regional market, supported by advanced healthcare infrastructure and high adoption of minimally invasive procedures. Asia-Pacific is expected to experience strong growth because of increasing healthcare expenditure, expanding diagnostic infrastructure, and rising medical procedure volumes.

Overall, innovation, infection-control requirements, cancer screening, and demand for accurate tissue sampling are expected to remain important drivers of the disposable biopsy needle industry through 2035.